Kira Pharmaceuticals lands $46m

Kira Pharmaceuticals, a developer of therapies to treat immune-mediated diseases, has secured $46 million in funding.

Kira Pharmaceuticals, a developer of therapies to treat immune-mediated diseases, has secured $46 million in funding. The backers included Quan Capital, 6 Dimensions Capital, Qiming Venture Partners and Sinopharm Capital.

Source: Press Release